Skip to main content
SpringerLink
Log in

Low-Energy Extracorporeal Shock Wave Therapy

  • Chapter
  • First Online:
Book cover Therapeutic Angiogenesis

  • 424 Accesses

Abstract

Despite recent advances in medical knowledge and technology, ischemic heart disease is still one of the major causes of death, with the morbidity increasing worldwide. We have recently developed a new, noninvasive angiogenic therapy using low-energy shock waves. Low-energy extracorporeal cardiac shock wave therapy improves myocardial ischemia in a porcine model of chronic myocardial ischemia and in patients with refractory angina pectoris. Shock wave therapy also improves walking ability in patients with peripheral arterial disease and ameliorates digital skin ulcers in patients with systemic sclerosis. Furthermore, animal studies suggest that shock wave therapy may be effective to suppress left ventricular remodeling after acute myocardial infarction and to enhance locomotor recovery after spinal cord injury. Here, we summarize the studies in animals and humans and discuss the advantages and perspectives of low-energy shock wave therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–18.

    Article  PubMed  Google Scholar 

  2. Japanese Coronary Artery Disease (JCAD) Study Investigators. Current status of the background of patients with coronary artery disease in Japan. Circ J. 2006;70:1256–62.

    Article  Google Scholar 

  3. Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2011;8:140–7. doi:10.1038/nrcardio.2010.199.

    Article  PubMed  Google Scholar 

  4. Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. Circ J. 2013;77:1923–32.

    Article  PubMed  Google Scholar 

  5. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110:3055–61.

    Article  PubMed  Google Scholar 

  6. Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, et al. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide. 2005;12:89–96.

    Article  CAS  PubMed  Google Scholar 

  7. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis. 2006;17:63–70.

    Article  PubMed  Google Scholar 

  8. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J. 2010;74:589–91.

    Article  PubMed  Google Scholar 

  9. Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D, Beurich H, Tölg R, Geist V, et al. Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. Int J Cardiol. 2007;121:84–5.

    Article  PubMed  Google Scholar 

  10. Prinz C, Lindner O, Bitter T, Hering D, Burchert W, Horstkotte D, et al. Extracorporeal cardiac shock wave therapy ameliorates clinical symptoms and improves regional myocardial blood flow in a patient with severe coronary artery disease and refractory angina. Case Rep Med. 2009;2009:639594. doi:10.1155/2009/639594.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN, et al. Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congest Heart Fail. 2010;16:226–30. doi:10.1111/j.1751-7133.2010.00182.x.

    Article  PubMed  Google Scholar 

  12. Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Sun S, et al. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease. Clin Cardiol. 2010;33:693–9. doi:10.1002/clc.20811.

    Article  PubMed  Google Scholar 

  13. Wang Y, Guo T, Ma TK, Cai HY, Tao SM, Peng YZ, et al. A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease. Cardiovasc Ultrasound. 2012;10:35. doi:10.1186/1476-7120-10-35.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Yang P, Guo T, Wang W, Peng YZ, Wang Y, Zhou P, et al. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease. Heart Vessel. 2013;28:284–91. doi:10.1007/s00380-012-0244-7.

    Article  Google Scholar 

  15. Schmid JP, Capoferri M, Wahl A, Eshtehardi P, Hess OM. Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial. Cardiovasc Ther. 2013;31:e1–6. doi:10.1111/j.1755-5922.2012.00313.x.

    Article  CAS  PubMed  Google Scholar 

  16. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, et al. MIYAGI-AMI study investigators. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI registry study. Circ J. 2010;74:93–100.

    Article  PubMed  Google Scholar 

  17. Olivetti G, Ricci R, Beghi C, Guideri G, Anversa P. Response of the border zone to myocardial infarction in rats. Am J Pathol. 1986;125:476–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis. 2007;18:397–404.

    Article  PubMed  Google Scholar 

  19. Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, Takeda M, et al. Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron Artery Dis. 2010;21:304–11.

    Article  PubMed  Google Scholar 

  20. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608–21.

    Article  CAS  PubMed  Google Scholar 

  21. Wennberg PW. Approach to the patient with peripheral arterial disease. Circulation. 2013;128:2241–50. doi:10.1161/CIRCULATIONAHA.113.000502.

    Article  PubMed  Google Scholar 

  22. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): the TASC steering committee. Catheter Cardiovasc Interv. 2015;86:611–25. doi:10.1002/ccd.26122.

    Article  PubMed  Google Scholar 

  23. Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, Hizume T, et al. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med. 2008;214:151–8.

    Article  PubMed  Google Scholar 

  24. Serizawa F, Ito K, Kawamura K, Tsuchida K, Hamada Y, Zukeran T, et al. Extracorporeal shock wave therapy improves the walking ability of patients with peripheral artery disease and intermittent claudication. Circ J. 2012;76:1486–93.

    Article  PubMed  Google Scholar 

  25. Tara S, Miyamoto M, Takagi G, Kirinoki-Ichikawa S, Tezuka A, Hada T, et al. Low-energy extracorporeal shock wave therapy improves microcirculation blood flow of ischemic limbs in patients with peripheral arterial disease: pilot study. J Nippon Med Sch. 2014;81:19–27.

    Article  PubMed  Google Scholar 

  26. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587–95.

    Article  CAS  PubMed  Google Scholar 

  27. Stojadinovic A, Elster EA, Anam K, et al. Angiogenic response to extracorporeal shock wave treatment in murine skin isografts. Angiogenesis. 2008;11:369–80. doi:10.1007/s10456-008-9120-6.

    Article  PubMed  Google Scholar 

  28. Yan X, Zeng B, Chai Y, et al. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg. 2008;61:646–53. doi:10.1097/SAP.0b013e318172ba1f.

    Article  CAS  PubMed  Google Scholar 

  29. Hayashi D, Kawakami K, Ito K, Ishii K, Tanno H, Imai Y, et al. Low-energy extracorporeal shock wave therapy enhances skin wound healing in diabetic mice: a critical role of endothelial nitric oxide synthase. Wound Repair Regen. 2012;20:887–95. doi:10.1111/j.1524-475X.2012.00851.x.

    Article  PubMed  Google Scholar 

  30. Weihs AM, Fuchs C, Teuschl AH, Hartinger J, Slezak P, Mittermayr R, et al. Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 2014;289:27090–104. doi:10.1074/jbc.M114.580936.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Saggini R, Figus A, Troccola A, et al. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol. 2008;34:1261–71. doi:10.1016/j.ultrasmedbio.2008.01.010.

    Article  CAS  PubMed  Google Scholar 

  32. Moretti B, Notarnicola A, Maggio G, Moretti L, Pascone M, Tafuri S, et al. The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord. 2009;10:54. doi:10.1186/1471-2474-10-54.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Saito S, Ishii T, Kamogawa Y, Watanabe R, Shirai T, Fujita Y, et al. Extracorporeal shock wave therapy for digital ulcers of systemic sclerosis: a phase 2 pilot study. Tohoku J Exp Med. 2016;238:39–47. doi:10.1620/tjem.238.39.

    Article  CAS  PubMed  Google Scholar 

  34. Kubo M, Li TS, Kamota T, Ohshima M, Shirasawa B, Hamano K. Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis. J Vasc Surg. 2010;52:429–34. doi:10.1016/j.jvs.2010.03.017.

    Article  PubMed  Google Scholar 

  35. Serizawa F, Ito K, Matsubara M, Sato A, Shimokawa H, Satomi S. Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphedema. Eur J Vasc Endovasc Surg. 2011;42:254–60. doi:10.1016/j.ejvs.2011.02.029.

    Article  CAS  PubMed  Google Scholar 

  36. Ogden JA, Alvarez RG, Levitt R, Marlow M. Shock wave therapy (Orthotripsy) in musculoskeletal disorders. Clin Orthop Relat Res. 2001;387:22–40.

    Article  Google Scholar 

  37. Birnbaum K, Wirtz DC, Siebert CH, et al. Use of extracorporeal shock-wave therapy (ESWT) in the treatment of non-unions. A review of the literature. Arch Orthop Trauma Surg. 2002;122:324–30.

    Article  CAS  PubMed  Google Scholar 

  38. Wang CJ. Extracorporeal shockwave therapy in musculoskeletal disorders. J Orthop Surg Res. 2012;7:11. doi:10.1186/1749-799X-7-11.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Al-Abbad H, Simon JV. The effectiveness of extracorporeal shock wave therapy on chronic achilles tendinopathy: a systematic review. Foot Ankle Int. 2013;34:33–41. doi:10.1177/1071100712464354.

    Article  PubMed  Google Scholar 

  40. Yamaya S, Ozawa H, Kanno H, Kishimoto KN, Sekiguchi A, Tateda S, et al. Low-energy extracorporeal shock wave therapy promotes VEGF expression and neuroprotection and improves locomotor recovery after spinal cord injury. J Neurosurg. 2014;121:1514–25. doi:10.3171/2014.8.JNS132562.

    Article  PubMed  Google Scholar 

  41. Yip HK, Chang LT, Sun CK, Youssef AA, Sheu JJ, Wang CJ. Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J. 2008;72:150–6.

    Article  CAS  PubMed  Google Scholar 

  42. Nurzynska D, Di Meglio F, Castaldo C, Arcucci A, Marlinghaus E, Russo S, et al. Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart. Ultrasound Med Biol. 2008;34:334–42.

    Article  PubMed  Google Scholar 

  43. Sheu JJ, Sun CK, Chang LT, Fang HY, Chung SY, Chua S, et al. Shock wave-pretreated bone marrow cells further improve left ventricular function after myocardial infarction in rabbits. Ann Vasc Surg. 2010;24:809–21. doi:10.1016/j.avsg.2010.03.027.

    Article  PubMed  Google Scholar 

  44. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation. 2006;114:2823–30.

    Article  PubMed  Google Scholar 

  45. Abe Y, Ito K, Hao K, Shindo T, Ogata T, Kagaya Y, et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ J. 2014;78:2915–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan

    Kenta Ito, Tomohiko Shindo & Hiroaki Shimokawa M.D., Ph.D.

Authors
  1. Kenta Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomohiko Shindo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroaki Shimokawa M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Shimokawa M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

    Yukihito Higashi

  2. Department of Cardiology, Nagoya University, Aichi, Japan

    Toyoaki Murohara

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Ito, K., Shindo, T., Shimokawa, H. (2017). Low-Energy Extracorporeal Shock Wave Therapy. In: Higashi, Y., Murohara, T. (eds) Therapeutic Angiogenesis. Springer, Singapore. https://doi.org/10.1007/978-981-10-2744-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-2744-4_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-2743-7

  • Online ISBN: 978-981-10-2744-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation